To determine real-life quantitative changes in OCT biomarkers in a large set of treatment naive patients in a real-life setting undergoing anti-VEGF therapy. For this purpose, we devised a novel deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results